Skip to main content
Veterinary Medicines

Peracef, 100mg, Intramamární suspenze

Not authorised
  • Cefoperazone

Product identification

Medicine name:
Peracef, 100mg, Intramamární suspenze
Active substance:
  • Cefoperazone
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefoperazone
    100.00
    milligram(s)
    /
    1.00
    Applicator
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        2
        day
      • Milk
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DD12
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Ceska Republika s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 96/1032/95-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."